SARS-CoV-2 3CLpro-IN-5

Biorbyt

SARS-CoV-2 3CLpro-IN-5

10

Research Use Only

98.00%

C22H26ClF2N5O4

497.92

SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor targeting the 3C-like protease (3CLpro), with potent inhibitory activity (IC50: 3.8 nM) and 9.0% oral bioavailability (BA), used in COVID-19 research [1].

-20°C

12352200